​Dr. Martin Paulus has been appointed to the Editorial Board at JAMA Psychiatry. This journal is the highest impact journal in psychiatry today. Dr. Paulus has reviewed articles on their behalf and because of the high quality, succinct and analytical reviews he provides, they invited him to formalize the relationship and secure his expertise.

This benefits LIBR in terms of increased visibility in the scientific community and by gaining insight into cutting edge research underway globally.
​
Congratulations, Dr. Paulus!

​LIBR is pleased to announce that we have been awarded a prestigious grant from the National Institutes of Health (NIH) along with 12 other research institutions as part of a landmark study about the effects of adolescent substance use on the developing brain. This study will be a unique opportunity for the Tulsa region to contribute to a national effort to better understand the brain.

The Adolescent Brain Cognitive Development (ABCD) Study will follow 10,000 children nationwide beginning at ages 9 to 10, through the period of highest risk for substance use and mental health disorders. Scientists will track exposure to substances, academic achievement, cognitive skills, mental health, and brain structure and function using advanced research methods.

Click here to read the official press release

Two of LIBR's principal investigators have been awarded the prestigious 2015 NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation!

Dr. Jonathan Savitz: "Efficacy of Influenza Vaccine in Major Depressive Disorder"

Dr. Sahib Khalsa: "Augmented Interoceptive Exposure Training as a New Treatment for Anxiety in Anorexia Nervosa"

Congratulations to both on this impressive accomplishment!

Congratulations to Dr. Paul Hamilton and Dr. Justin Feinstein for being named as 2015 American College of Neuropsychopharmacology (ACNP) Travel Awardees! They were two of 58 recipients from a competitive and talented pool of 338 applicants, the highest and most diverse in ACNP's history.

This accomplishment provides them with a number of benefits for the upcoming December meeting in Hollywood, Florida, including registration, lodging, round-trip airfare, an ACNP mentor, a special travel awardee reception and poster session and an invitation to attend the meeting for the next four years.

http://www.acnp.org/

Dr. Maurizio Bergamino and his co-authors have been named as the 2014 Galileo Galilei Award recipients from the European Journal of Medical Physics- Physica Medica (EJMP). His first-author paper "A review of technical aspects of T1-weighted dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in human brain tumors" was selected as the best publication in EJMP in 2014. 

Full article reference: A review of technical aspects of T1‐weighted dynamic contrast‐enhanced magnetic resonance imaging (DCEMRI) in human brain tumors by M. Bergamino, L. Bonzano, F. Levrero, G. L. Mancardi, L. Roccatagliata, published in Physica Medica, Volume 30, Issue 6, September 2014, Pages 635‐643.

In his award letter, the Editor-in-Chief noted that "The Editorial team felt that this work gives a useful review of the technical issues involved in DCE‐MRI in the in vivo study of patients with brain tumors, with a focus of estimating the blood brain barrier permeability. Both theoretical models and experimental procedures are described; particularly useful is the description of data acquisition details, arterial input function assessment and methods for image analysis, so highlighting the role of the medical physicist in the assessment of this diagnostic imaging procedure".

Congratulations to Maurizio on this impressive achievement!